key: cord-0265044-68wd71kg
authors: Israeli, Ma’ayan; Finkel, Yaara; Israeli, Ofir; Beth-Din, Adi; Cohen-Gihon, Inbar; Yahalom-Rone, Yfat; Paran, Nir; Israely, Tomer; Chitlaru, Theodor; Elia, Uri; Cohen, Ofer; Nemet, Ital; Kliker, Limor; Mandelboim, Michal; Stern-Ginossar, Noam; Bercovich-Kinori, Adi
title: CRISPR screens for host factors critical for infection by SARS-CoV-2 variants of concern identify GATA6 as a central modulator of ACE2
date: 2021-07-20
journal: bioRxiv
DOI: 10.1101/2021.07.19.452809
sha: 80e45e5ebac888aa14aa42cce27cc3255ccfc6fe
doc_id: 265044
cord_uid: 68wd71kg

The global spread of SARS-CoV-2 lead to the most challenging pandemic in this century, posing major economic and health challenges worldwide. Revealing host genes essential for infection by multiple variants of SASR-CoV-2 can provide insights into the virus pathogenesis, and facilitates the development of novel broad-spectrum host-directed therapeutics. Here, employing genome-scale CRISPR screens, we provide a comprehensive data-set of cellular factors that are exploited by WT-SARS-CoV-2 as well as two additional recently emerged variants of concerns (VOCs), Alpha and Beta. These screens identified known and novel host factors critical for SARS-CoV-2 infection, including various components belonging to the Clathrin-dependent transport pathway, ubiquitination and Heparan sulfate biogenesis. In addition, the host metabolic pathways pertaining to mitochondrial activity as well as phosphatidylglycerol biosynthesis processes appeared to have major anti-viral functions. Comparative analysis between the different VOCs revealed the receptor KREMEN2 as unique gene required only to the Alpha variant, providing a possible explanation for the increased infectivity of this variant. Furthermore, the analysis identified GATA6, a zinc finger transcription factor, as an essential pro-viral gene for all variants inspected. We reveal that GATA6 directly regulates ACE2 transcription and is accordingly, critical for SARS-CoV-2 cell entry. Analysis of clinical samples collected from SARS-CoV-2 infected individuals showed an elevated level of GATA6, indicating the important role GATA6 may be playing in COVID-19 pathogenesis. Finally, pharmacological inhibition of GATA6 results in down-modulation of ACE2 and consequently to inhibition of the viral infectivity. Overall, we show GATA6 represents a target for the development of anti-SARS-CoV-2 therapeutic strategies and reaffirm the value of the CRISPR loss-of-function screens in providing a list of potential new targets for therapeutic interventions.

Coronaviruses are enveloped, positive-sense single-stranded RNA viruses with a genome of approximately 30 kb in length [1] . The initial steps of SARS-CoV-2 infection involve the specific binding of the coronavirus spike protein (S) to the cellular entry receptor angiotensin-converting enzyme 2 (ACE2) [2] [3] [4] [5] . The binding to the receptor and the subsequent membrane fusion commences the process of viral entry into the host cell by endocytosis allowing the virion to release the genetic material into the cytoplasm where it is translated into continuous polypeptides that are cleaved into 16 nonstructural proteins, which then facilitate the transcription of sub-genomic RNA that is translated into structural and accessory proteins. These viral proteins rearrange host membranes to form the endoplasmic reticulumlocalized viral replication complex (RC) in which the viral genomic RNA is replicated by the viral RNA-dependent RNA polymerase (RdRP) complex. The assembled components further undergo maturation in the Golgi apparatus to form the mature virion that is released outside the host cell by exocytosis [1, [6] [7] [8] . Every step of the viral life cycle, from entry to budding, is orchestrated through interactions with host cellular proteins. For example, cellular proteases, such as TMPRSS2, Cathepsin L, and Furin, are exploited for the cleavage of the viral spike protein of SARS-CoV-2, mediating efficient membrane fusion with the infected cell [9] [10] [11] [12] [13] . Identification of additional key host proteins involved in the various steps of the infection is essential for the development of countermeasures and represents the objective of intense efforts. Several proteomics studies addressed the SARS-CoV-2-host interactions by utilizing immunoprecipitation mass spectrometry (IP-MS) of affinity-tagged viral proteins and proximity labeling of the virus replicase complex [14] [15] [16] [17] . The proteomics approach revealed comprehensive interactomes and physical contacts between many viral and cellular proteins, and highlighted potential targets for drug repurposing. Yet, this approach cannot provide direct information about the essentiality of these host components for enabling the SARS-CoV-2 life cycle. Another strategy to explore SARS-CoV-2-host interactions is to disrupt individual genes of the entire host genome and screen for genes whose disruption results in resistance to viral infection and consequently to host-cell survival. Several reports documented genome-wide CRISPR-Cas9-mediated loss-of-function screens and identify host factors that are functionally required for SARS-CoV-2 infection in various cell types [10, [18] [19] [20] [21] [22] [23] [24] [25] .

These studies identified genes, metabolic and signaling networks that previously have not been considered as potential therapeutic targets for SARS-CoV-2, such as the cholesterol synthesis pathways [19] .

As of today, following a year-long period of combating Covid-19 essentially by medical care and social distancing, the contribution of many effective vaccines started to materialize [26, 27] . Covid-19 vaccines showed as high as 95% efficacy in preventing clinical cases and 100% efficacy in preventing severe disease with original viral variants [28, 29] . The average mutation rate of SARS-CoV-2 remains low and steady. However, the continuing global spread of the SARS-CoV-2, together with selective pressure for immune escape, led to the emergence of new SARS-CoV-2 variants raising concerns regarding their relative ability to escape from natural and vaccine-induced immunity. Four novel variants that generated different patterns in the pandemic expansion, are of considerable public-health concern, as concluded by the WHO organization following judicious monitoring and classification of the new lineages (hence eloquently coined VOC, acronym for variants of concern): (i) Alpha (also known as B. The Beta variant emerged independently of the Alpha variant but shares with it mutations at several loci. The significant anxiety caused by this variant, owe to the co-occurrence of the N501Y mutation in the spike protein receptor binding domain (RBD, also found in the Alpha variant) with additional mutations K417N/T and E484K. Viral variants with the triple combination of mutations exhibit reduced susceptibility to vaccine-induced and convalescent sera [35] [36] [37] [38] [39] [40] [41] . Fortunately, the Beta variant is less abundant with a reported worldwide daily prevalence of 1% [42, 43] . In addition to the assessment of full immunological and clinical implications of the SARS-CoV-2 new variants, there is an urgent need for a more profound understanding of their biology, and for integrating this information towards the development of therapeutic approaches targeting host elements essential to all variants.

In this study we have performed a genome-wide CRISPR loss-of-function screen in a lung derived human cell line infected with SARS-CoV-2. In an attempt to probe shared and differential host factors that may be essential for the virus in the course of infection we expanded our genomic approach to the WT SARS-CoV-2 and two additional VOCs. This strategy led to the discovery of known and novel SARS-CoV-2-host interactions, enabled the identification of both common factors as well as those specific for particular variant, and revealed a pivotal role of the host pleiotropic regulator GATA6 which may represent a promising target for therapy.

Genome wide CRISPR screens for the identification of host factors essential for

To identify host factors essential for cell survival in response to human SARS-CoV-2, a CRISPR-based genome-wide gene-knockout screen was performed using the human lung epithelial cell line Calu-3, which is highly permissive to SARS-CoV-2 infection due to elevated levels of endogenous ACE2 expression. The library employed for the screen was the Brunello CRISPR library composed of 76,441 targeting single guide RNAs (sgRNAs) with an average of four gRNAs per gene and 1,000 non-targeting control sgRNAs [44] . For the identification of host factors exhibiting either broad or restricted essentiality for the different variants of SARS-Cov-2, Calu-3 cells transduced with the CRISPR library, were infected separately with each of the SARS-CoV-2 variants of concern (VOCs): SARS-CoV-2 B.1.1.7(Alpha), SARS-CoV-2 B.1.351 (Beta), and the original wild-type (WT) SARS-CoV-2 (GISAID accession EPI_ISL_406862). Genomic DNA was harvested from surviving cells 7-9 days post infection, and sgRNAs abundance was determined by sequencing (Fig.1A) . Integration of the datasets generated by screening cells infected with these various SARS-CoV-2 variants identified numerous genes which upon disruption, conferred resistance to death by viral infection (referred to as pro-viral) or sensitization to viral infection (referred to as anti-viral). The sgRNA score-distribution of the full library and that of sgRNA targeting the top hits for pro-and anti-viral genes demonstrated high technical quality of the screens ( Fig 1B) . As expected, the pro-viral gene, exhibiting the highest enrichment score was ACE2, the receptor serving as the portal for SARS-CoV-2 cell-entry (log fold change (LFC)=1.534, false discovery rate (FDR)= 0.007).

The transcription factor GATA6 (GATA Binding Protein 6) scored as the secondstrongest pro-viral hit (LFC=1.24, FDR= 0.028) ( Figure 1C, 1D ). GATA6 is a DNAbinding protein belonging to a family of zinc finger transcription factors that participate in the regulation of cellular differentiation during vertebrate development and contributes to immune regulation through various pathways such as NF-kB. Interestingly, the transcription level of GATA6 was shown to be elevated in the lung transcriptome of Covid-19 patients [45] . Other top pro-viral hits included CUL5, IRF6, AP1G1, EP300 and EXTL2 ( Figure 1C, 1D) . The CUL5 gene encodes Cullin5, a core component of multiple SCF-like ECS (Elongin-Cullin 2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. While ubiquitination of viral proteins can be used by the host as a defense mechanism by destroying the incoming pathogen, viruses have adapted to exploit this cellular process to enhance various steps of the replication cycle and increase pathogenesis [46] .

Indeed, in addition to highly modified ubiquitin-proteome of SARS-CoV-2-Infected host cells, ubiquitination modifications were observed also on SARS-CoV-2 proteins, and these modifications were reported to inhibit the host innate immune response [46] [47] [48] . IRF6 gene is a transcriptional activator with well-established role in the development of the epidermis. A recent study suggests a role for IRF6 in the modulation of the NFk-B-pathway that influences cell-survival by regulating host responses during viral infection, such as cytokine production [49] . AP1G1 (Adaptor Related Protein Complex 1 Subunit Gamma 1) encodes a component of clathrincoated vesicles that were shown to mediate endocytosis and intracellular trafficking of SARS-CoV-2 [50, 51] . Of note, the clathrin-coating complex, to which AP1G1 belongs, was recently identified as important for SARS-CoV-2 infectivity in a screen conducted in Calu-3 cells but not in screens conducted in other cell lines [21] . Taken together, the data therefore suggest that some of the host entry factors necessary for SARS infection exhibit cell-line specificity illustrating the importance of using relevant cell models to maximize our understanding of SARS-CoV-2 entry.

EP300 encodes a histone acetyltransferase that is recruited by SMAD complexes to activate target genes in response to TGF-β receptor signaling [52] . Interestingly, in a recent search for functional modifiers of ACE2 surface abundance, EP300 was found to regulate ACE2 transcription and hence to influence cellular susceptibility to SARS-CoV-2 infection [53] . EXTL2 encodes a glycosyltransferase involved in the chain elongation step of heparan sulfate (HS) biosynthesis [54, 55] . Several heparan sulfate biosynthetic genes were also markedly enriched in other CRISPR knockout SARS-CoV-2 screens conducted in Huh7.5.1 cells [22, 23] consistent with a recent report that SARS-CoV-2 infection is co-dependent on heparan sulfate and ACE2 [56] . Since HS is ubiquitously expressed on the surfaces and in the extracellular matrix of all cell types, EXTL2 may play a central pro-viral role through heparan sulfate production that may determine SARS-CoV-2 tropism. RPP21 encodes a subunit of nuclear ribonuclease P, which processes the 5-prime leader sequence of precursor tRNAs [57] . UQCRC1 encodes a component of the ubiquinol-cytochrome c oxidoreductasel that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. Similarly to a previous survey [10] , the present screen also distinguished a significant enrichment of mitochondrial ribosomal proteins (MRPS) genes (e.g., MRPL17, MRPS33, MRPL41, MRPL34, MRPL53 and MRPS12) (highlighted in red in Figure 1D ). The emerging notion of the role of mitochondrial dynamics in viral infections, unequivocally attribute mitochondria with a key role for cellular metabolism and innate immunity. Overall, the corroboration of previously reported entry factors reported here, together with novel pro-viral host genes and the implied functional pathways, demonstrates the high potential of CRISPR-knockout screens to distinguish targets for host dependent anti-viral therapy. S1 ). As expected, while WT Calu-3 cells display cytopathic effect following SARS-CoV-2 infection, ACE2 gene-disruption protected cells from the infection (Fig. 4A ).

In agreement with the results of our CRISPR screens, GATA6-disrupted cells were also almost fully protected from cell death following SARS-CoV-2 infection.

Furthermore, the extent of resilience to viral infection was commensurate with that exhibited by cells in which ACE2 expression was abrogated (Fig. 4A ). Further investigation of SARS-CoV-2 viral load in infected GATA6-disrupted cells demonstrated significant reduction of viral replication 48 hours post infection subsequent to reduction in GATA6 content (Fig. 4B ).

Since GATA6 did not emerged as essential for SARS-CoV-2 infection in previously published SARS-CoV-2 CRISPR screens carried in other cell types, we addressed the possibility that the observed phenomenon is related to GATA6 expression in different cell types. Inspection of the relative expression levels of GATA6 in published datasets of Calu-3, A549 and Vero-E6 cell lines [66] [67] [68] , revealed that GATA6 is indeed expressed at much higher levels in Calu-3 cells (Fig 4C) .

Furthermore, the relative levels of GATA6 increased along infection of Calu-3 cells ( Fig 4D) . It is therefore conceivable that the function fulfilled by GATA6 in Calu-3 cells is not identical to that in A549 and Vero-E6, in line with the fact that GATA6 GATA6 is a novel regulator of ACE2 that may serve as a potential host directed therapeutic target

Since SARS-CoV-2 entry into cells is primarily mediated by ACE2, the expression of ACE2 in these cells was determined by Western-blot analysis. The analysis included WT, ACE2 disrupted, and GATA6 disrupted cells. Notably, the decrease in GATA6 was followed by a significant reduction in ACE2 expression compared to control cells (Fig. 5B ). Real-Time PCR analysis validated the Western-blot results indicating that this effect involves a regulatory mechanism exerted at the transcriptome-level, suggesting that GATA6 acts as a transcriptional factor affecting ACE2 expression (Fig. 5C ). In an attempt to further confirm these results and determine the possible temporal connection between GATA6 expression and that of ACE2, the expression of GATA6 was abrogated by siRNA targeting and the expression of ACE2 was interrogated at early time-points post GATA6 silencing.

The analysis shows that ACE2 expression decreases as soon as 12 hours post GATA6-siRNA transfection (Fig. 5D ).

GATA6 is a known transcription factor recognizing well-defined DNA-binding specific sites (T/AGATAA/G or reverse complement sequences C/TTATCT/A) [69] .

Accordingly, the promoter of the ACE2 gene was screened for the GATA6 consensus DNA binding site. The conserved GATA-binding motif was found at nucleotide positions −341 and −403 (where the A of the ATG codon is +1) ( Figure   5E ) [70] . To further investigate the possible sequence-specific binding of GATA6

to ACE2 promoter an Electrophoretic Mobility Shift Assays (EMSA) was applied.

Incubation of lysates from HEK293T cells over expressing GATA6 with labeled oligonucleotides derived from the promoter region of ACE2 results in the formation of protein-DNA complexes, which was prevented by competitive unlabeled oligonucleotides (Fig. 5F ). This observation supports the notion that GATA6 may induce the expression of ACE2 directly via a sequence-specific GATA6 binding sites.

CRISPR loss-of-function surveys for host factors based on virus-induced cell death, may identify genes encoding for products essential to the virus, and yet dispensable to cell viability. Accordingly, such host factors may serve as excellent candidates for antiviral therapy. Therefore, we explored whether pharmacological inhibition of GATA6 affects ACE2 expression and consequently, coronavirus infection. Pyrrothiogatain, previously reported to inhibit the DNA-binding activity of GATA6 and other members of the GATA family [71] , was tested for its ability to induce downregulation of ACE2 and subsequent inhibition of viral infection. As expected, the drug exhibited a dose-dependent inhibition of GATA6 accompanied by insignificant cytotoxicity in Calu-3 cells (Fig. S2) . Inhibition of GATA6 resulted in a lower ACE2 expression (Fig. 5G, Fig.S1 ) confirming the causal connection between GATA6 and ACE2. Next, cells pretreated with Pyrrothiogatain for 48 hours were infected with SARS-CoV-2. Immunofluorescence analysis evidenced cytoplasmic SARS-CoV-2 staining in untreated cells while significantly reduced infection was observed in Pyrrothiogatain-treated cells (Fig. 5H) . The data strongly supports the possibility that novel therapeutic strategies to countermeasure viral infection via down-modulation of ACE2 may employ specific GATA6 targeting. 

To generate CRISPR KO libraries, a total of 4*10 8 supplementary Table S1 .

Pooled PCR products were purified with Agencourt AMPure XP-SPRI magnetic beads according to manufacturer's instruction (Beckman Coulter, A63880).

Samples were sequenced on a Illumine MiSeq platform. Reads were counted by alignment to a reference file of all possible sgRNA present in the library. The read was then assigned to a condition on the basis of the 8 nt index included in the p7 primer. The lentiviral plasmid DNA pool was sequenced as a reference.

MAGeCK v0.5.6 [73] was used to count sgRNA from FASTQ files and to analyze the selection effect of genes based on the change in sgRNA distribution, using the robust rank aggregation (RRA) algorithm with normalization to total reads. Directed score for each gene was calculated by taking the enrichment MAGeCK RRA scores for genes with a positive fold change from control and the depletion MAGeCK RRA score for genes with a negative or zero-fold change. Directed scores for sgRNAs was calculated by multiplying the MAGeCK sgRNA scores by 1 or (-1) according to the direction of change. These scores were scaled to sd=1 and centered to the mean.

Directed scores were used as input for gene set enrichment analysis (GSEA The STRING network was imported into Cytoscape [76] . Genes were highlighted based on association with selected REACTOME pathways. Genes that were not highlighted or connected to at least two other genes were excluded from the graph.

DNA oligos (Integrated DNA Technologies, Inc.) containing sgRNA sequences (see supplementary Table S1 ) were annealed and ligated into lentiCRISPRv2 

Negative and positive qRT-PCR nasopharyngeal swab samples from symptomatic and asymptomatic individuals were collected as part of routine scanning of nursing Scaled directed score TOP3A  SNUPN  PRADC1  THOC6  ECSIT  SLC2A1  TMEM242  NDUFB10  NDUFB7 NDUFB7  CD2BP2  CFAP69 F F  CAND1  DHX30  TAF1C T T   LONP1   C10orf2  SESN2  EDC4 EDC4  TSEN2  RAD1  UBE2G2 UBE2G2   LMX1A  ELAVL1 A A  BICD1   HECTD3  NHP2  LOC100287036  VRK1  CENPO   ECSIT  THOC6  POLE4  PRADC1  THOC6  DHX30  SLC2A1  AP69  C10orf2  SESN2  TSEN2  PRADC1  SESN2  TSEN2  UBE2G2  EDC4  CENPO  LOC100287036  RAD1  EDC4  LOC100287036  EDC4 with antisera against SARS-CoV-2 (green) and DAPI (blue). Scale bar, 20mm.

Human Coronavirus: Host-Pathogen Interaction

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

A pneumonia outbreak associated with a new coronavirus of probable bat origin

The molecular virology of coronaviruses

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Coronavirus biology and replication: implications for SARS-CoV-2

TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling. Elife

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2. bioRxiv

Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection. bioRxiv

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Signals of hope: gauging the impact of a rapid national vaccination campaign

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New SARS-CoV-2 Variants -Clinical, Public Health, and Vaccine Implications

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Detection of a SARS-CoV-2 variant of concern in South Africa

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. bioRxiv

Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2. Lancet Microbe

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv

Investigation of novel SARS-CoV-2 variant -Variant of Concern 202012/01 -Technical briefing 3 London

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy

The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses. Viruses

Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response

Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis

Interferon Regulatory Factor 6 Has a Protective Role in the Host Response to Endotoxic Shock

SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis

SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

Identification of ACE2 modifiers by CRISPR screening. bioRxiv

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? Viruses

How does cellular heparan sulfate function in viral pathogenicity?

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Function and subnuclear distribution of Rpp21, a protein subunit of the human ribonucleoprotein ribonuclease P. Rna

Phospholipid regulation of innate immunity and respiratory viral infection

Phosphatidylglycerol and surfactant: A potential treatment for COVID-19? Med Hypotheses

Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling

Structure of the Dual-Mode Wnt Regulator Kremen1 and Insight into Ternary Complex Formation with LRP6 and Dickkopf

KREMEN1 Is a Host Entry Receptor for a Major Group of Enteroviruses

Interaction network of SARS-CoV-2 with host receptome through spike protein. bioRxiv

GATA-6 activates transcription of surfactant protein A

Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2

The coding capacity of SARS-CoV-2

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

A systematic view on influenza induced host shutoff. Elife

ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus)

The transcription factor HNF1α induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs

Pyrrothiogatain acts as an inhibitor of GATA family proteins and inhibits Th2 cell differentiation in vitro

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles

The Molecular Signatures Database (MSigDB) hallmark gene set collection

Cytoscape: a software environment for integrated models of biomolecular interaction networks

We thank Tamar Aminov and Inbar Chomsky for technical assistance. We thank Emanuelle Mamroud for providing valuable feedback